Group 1 - The core point of the article is the disclosure of institutional holdings in Zhongyan Dadi (003001.SZ) as of October 30, 2025, indicating a decrease in institutional ownership compared to the previous quarter [1] - As of the reporting date, there are 2 institutional investors holding a total of 9.52 million shares, which represents 5.39% of Zhongyan Dadi's total share capital [1] - The institutional ownership has decreased by 1.34 percentage points compared to the previous quarter [1] Group 2 - The report mentions 19 public funds that have not disclosed their holdings in the current period, including notable funds such as China Merchants Ruiqing Mixed A and Rongtong New Trend Flexible Allocation Mixed [1]

Core Insights - International Medicine (000516.SZ) reported its Q3 2025 results on October 30, 2025, highlighting significant institutional investment activity [1] Institutional Holdings - As of October 29, 2025, six institutional investors disclosed holdings in International Medicine A-shares, totaling 754 million shares, which represents 33.67% of the company's total equity [1] - The institutional holding percentage increased by 0.45 percentage points compared to the previous quarter [1] Public Fund Activity - In this reporting period, 16 public funds were disclosed, including Jin Ying Theme Advantage Mixed, Huatai-PB Healthcare A, Guotai Rongan Multi-Strategy Flexible Allocation Mixed A, Penghua Healthcare Stocks, and Penghua Pension Industry Stocks [1] Foreign Investment - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings, contributing an increase of 0.52% compared to the previous period [1]

Group 1 - The core viewpoint of the news is that Jincheng Pharmaceutical (300233.SZ) has seen an increase in institutional investor holdings, with a total of 1.13 billion shares held by 9 institutions, representing 29.44% of the total share capital, which is an increase of 4.77 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 2 new public funds disclosed their holdings in Jincheng Pharmaceutical this quarter, including the Fuguo Precision Medical Flexible Allocation Mixed Fund and the Xingquan Light Asset Mixed Fund (LOF) [1] - A total of 14 public funds were not disclosed this quarter, including major funds such as Dachen Jingheng Mixed A and Dachen Zhuoxiang One-Year Holding Mixed A [1] Group 3 - For social security funds, 2 new social security funds disclosed their holdings in Jincheng Pharmaceutical, namely the National Social Security Fund 502 Portfolio and the National Social Security Fund 601 Portfolio [2] - In terms of foreign investment, one foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.56% compared to the previous quarter [2]